Novo Holdings to sell 7.8% stake in UK's Convatec, bookrunner says
17/11/2025 16:57
Nov 17 (Reuters) - Novo Holdings, which controls obesity drugmaker Novo Nordisk NOVOb.CO, will sell 155 million shares, or about 7.8% of its stake, in British medical products maker Convatec Group CTEC.L, a bookrunner for the offering said on Monday. (Reporting by Shashwat Awasthi in Bengaluru; Editing by Shilpi Majumdar) ((Shashwat.Awasthi@tr.com))